LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias

We report the design of a targeted resequencing panel for monogenic dyslipidemias, LipidSeq, for the purpose of replacing Sanger sequencing in the clinical detection of dyslipidemia-causing variants. We also evaluate the performance of the LipidSeq approach versus Sanger sequencing in 84 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Christopher T., Dubé, Joseph B., Loyzer, Melissa N., MacDonald, Austin, Carter, David E., McIntyre, Adam D., Cao, Henian, Wang, Jian, Robinson, John F., Hegele, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2014
Materias:
Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966710/
https://www.ncbi.nlm.nih.gov/pubmed/24503134
http://dx.doi.org/10.1194/jlr.D045963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966710/
https://www.ncbi.nlm.nih.gov/pubmed/24503134
http://dx.doi.org/10.1194/jlr.D045963

Ejemplares similares